ERBB2 and small cell lung carcinoma: To further evaluate the cytotoxicity to primary cancer cells, MPE was obtained from a small cell lung cancer (SCLC) patient (Pt10) and confirmed by pathologists (Supplementary Fig. S4), HER2 and PD-L1 expressions on cancer cells were detected by flow cytometry (Fig. 3i).